Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 535.00
Bid: 536.20
Ask: 536.40
Change: -2.40 (-0.45%)
Spread: 0.20 (0.037%)
Open: 536.40
High: 538.60
Low: 534.00
Prev. Close: 537.40
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of Offer Price

12 Jun 2014 07:00

RNS Number : 4261J
B&M European Value Retail S.A.
12 June 2014
 



 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

 

This announcement is an advertisement for the purposes of article 17 of the Grand-Duchy of Luxembourg law of 10 July 2005 on prospectus for securities, as amended (the "Luxembourg Prospectus Law") and not a prospectus. This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in any jurisdiction, including in or into the United States, Canada, Japan or Australia.

 

Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not purchase or subscribe for any ordinary shares ("Shares") of B&M European Value Retail S.A. (the "Company") referred to in this announcement other than solely on the basis of information that is contained in the prospectus (the "Prospectus") which is expected to be shortly published by the Company in due course in connection with the proposed admission of its Shares to the premium listing segment of the Official List of the Financial Conduct Authority (the "FCA") and to trading on the main market for listed securities of London Stock Exchange plc (the "London Stock Exchange") ("Admission"). Copies of the Prospectus will, following publication, be available for inspection from www.bandmretail.com. References in this announcement to "B&M" or the "Group" mean the Company, together with its consolidated subsidiaries and subsidiary undertakings following a pre-IPO reorganisation.

 

 

FOR IMMEDIATE RELEASE

 

12 June 2014

 

B&M European Value Retail S.A.

 

Announcement of Offer Price

 

B&M European Value Retail S.A. (the "Company"), the general merchandise discount retailer, today announces the successful pricing of its initial public offering (the "Global Offer" or "IPO") at 270 pence per Share (the "Offer Price").

 

*

Based on the Offer Price, the market capitalisation of the Company at the commencement of conditional dealings will be GBP 2,700 million.

 

 

*

The Global Offer is expected to raise total gross proceeds of approximately GBP 1,080 million assuming no exercise of the Over-Allotment Option. If the Over-Allotment Option was exercised in full the total gross proceeds of the Global Offer would be approximately GBP 1,188 million.

 

 

*

The Company will receive approximately GBP 75 million of gross proceeds from the Global Offer.

 

 

*

The selling shareholders will receive approximately GBP 1,005 million of gross proceeds from the Global Offer and comprise Simon Arora, Bobby Arora and Robin Arora (either directly or indirectly) (together, the "Arora Family") and Clayton, Dubilier & Rice Fund VIII, L.P., a fund managed by Clayton, Dubilier & Rice, LLC and certain other co-investment vehicles acting through CD&R European Value Retail Investment S.à r.l. ("CD&R Holdco"), assuming no exercise of the Over-Allotment Option.

 

 

*

The Global Offer comprises 400,000,000 Shares (excluding Over-Allotment arrangements) representing 40.0 per cent of the Company's issued ordinary share capital on Admission.

 

 

*

Conditional dealings in the Shares will commence on the London Stock Exchange at 8.00 a.m. today under the ticker "BME" (ISIN: LU1072616219).

 

 

*

Admission and the commencement of unconditional dealings in the Shares are expected to take place at 8.00 a.m. on 17 June 2014. At Admission the Company will have 1,000,000,000 Shares in issue.

 

 

*

BofA Merrill Lynch as stabilisation manager on behalf of the syndicate (the "Stabilisation Manager") has been granted an over-allotment option (the "Over-Allotment Option") by the Arora Family and CD&R Holdco (together, the "Over-Allotment Shareholders") to acquire, or procure acquirers for, up to an additional 40,000,000 Shares (the "Over-Allotment Shares"), representing up to a maximum of 10 per cent of the total number of Shares comprised in the Global Offer.

 

Commenting on today's announcement, Simon Arora, Chief Executive Officer of B&M, said:

 

"We are delighted that investors have demonstrated their support for B&M and its growth story in the value sector and that they share our excitement about the Group's future. We believe that becoming a public company gives us the right long-term ownership model, allowing us to build on our strong track record as we move to the next stage of development. We look forward to continuing to offer incredible value to our loyal customers, to bring the B&M experience to more people as we roll out stores and to breathe life into high streets and retail parks across Britain, creating thousands of jobs each year."

 

Further Information

 

*

The Company (365 days), the Arora Family (365 days) and CD&R Holdco (180 days) are subject to a lock-up period following Admission.

 

 

*

All lock-up arrangements are subject to certain customary exceptions.

 

 

*

In relation to the Global Offer and Admission, BofA Merrill Lynch and Goldman Sachs International are acting as Joint Sponsors, Joint Global Co-ordinators and Joint Bookrunners, Credit Suisse Securities (Europe) Limited and Deutsche Bank AG, London Branch are acting as Joint Bookrunners and Numis Securities Limited and Jefferies International Limited are acting as Co-lead Managers. Lazard & Co., Limited and N.M. Rothschild & Sons Limited are acting as financial adviser to the Company and the Arora Family, respectively.

 

Enquiries

 

B&M

+44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

 

Paul McDonald, Finance Director

 

 

 

Joint Global Co-ordinators, Joint Sponsors and Joint Bookrunners

 

BofA Merrill Lynch

+44 (0) 207 174 4000

George Close-Brooks

 

Andrew Tusa

 

Craig Coben

 

Milan Hasecic

 

 

 

Goldman Sachs International

+44 (0) 207 774 1000

Anthony Gutman

 

Richard Cormack

 

Nick Harper

 

Michael Casey

 

 

 

Joint Bookrunners

 

Credit Suisse

+44 (0) 20 7888 8888

Nick Williams

 

Michael Heuberger

 

Lewis Burnett

 

 

 

Deutsche Bank

+44 (0) 20 7545 8000

Alexis Maskell

 

Scott Bell

 

Lorcan O'Shea

 

 

 

Financial adviser to the Company

 

Lazard

+44 (0) 20 7187 2000

Charlie Foreman

 

Robert Brownell

 

Aamir Khan

 

 

 

Financial adviser to the Arora Family

 

Rothschild

+44 (0) 20 7280 5000

Majid Ishaq

 

Paul Mitchell

 

 

 

Public Relations

 

Tulchan Communications

+44 (0) 20 7353 4200

Susanna Voyle

 

Jonathan Sibun

 

 

Disclaimer

 

The contents of this announcement, which have been prepared by and are the sole responsibility of the Company, have been approved by Merrill Lynch International, 2 King Edward Street, London EC1A 1HQ and Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB solely for the purposes of section 21(2)(b) of the Financial Services and Markets Act 2000, as amended.

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its completeness, accuracy or fairness.

 

Neither this announcement nor the information contained herein is for publication, distribution or release, in whole or in part, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia (other than to persons in Australia to whom an offer may be made without a disclosure document in accordance with Chapter 6D of the Corporations Act 2001 (CTH) of Australia), Canada or Japan, including to any branch or agency of a non-U.S. person located in the United States or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction. The Global Offer and the distribution of this announcement and other information in connection with Admission and the Global Offer may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, Shares to any person in the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The Shares referred to herein may not be offered or sold in the United States unless registered under the US Securities Act of 1933, as amended (the "Securities Act") or offered in a transaction exempt from, or not subject to, the registration requirements of the Securities Act. The offer and sale of Shares referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. Subject to certain exceptions, the Shares referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. There will be no public offer of the Shares in the United States, Australia, Canada or Japan.

 

This announcement is only addressed to and directed at persons in member states of the European Economic Area ("EEA") who are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC), as amended ("Qualified Investors"). In addition, in the United Kingdom, this announcement is addressed and directed only at Qualified Investors who (i) are persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), (ii) are persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order and (iii) to persons to whom it may otherwise be lawful to communicate it to (all such persons being referred to as "relevant persons"). Any investment or investment activity to which this announcement relates is available only to relevant persons in the United Kingdom and Qualified Investors in any member state of the EEA other than the United Kingdom and will be engaged in only with such persons. Other persons should not rely or act upon this announcement or any of its contents.

 

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. As a result, investors should not rely on such forward-looking statements in making their investment decisions. No representation or warranty is made as to the achievement or reasonableness of and no reliance should be placed on such forward-looking statements. Any forward-looking statements reflect the Group's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Group's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly the results of any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

 

Each of Merrill Lynch International, Goldman Sachs International, Credit Suisse Securities (Europe) Limited, Deutsche Bank AG, London Branch, Numis Securities Limited and Jefferies International Limited (together, the "Banks") and the Company and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statement contained in this announcement whether as a result of new information, future developments or otherwise.

 

This announcement is an advertisement for the purposes of the Luxembourg Prospectus Law and not a prospectus. Any purchase or subscription of Shares in the proposed IPO should be made solely on the basis of the information contained in the Prospectus to be issued by the Company in connection with the Global Offer and Admission. No reliance may or should be placed by any person for any purposes whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness. The information in this announcement is subject to change.

 

The IPO timetable, including the date of Admission, may be influenced by a range of circumstances such as market conditions. There is no guarantee that the Global Offer and Admission will occur and you should not base your financial decisions on the Company's intentions in relation to the Global Offer and Admission at this stage. Acquiring investments to which this announcement relates may expose an investor to a significant risk of losing all or part of the amount invested. Before purchasing any Shares, persons viewing this announcement or any of the documents relating to the Offer should ensure that they fully understand and accept the risks that are set out in the Prospectus. Persons considering making such investments should consult an authorised person specialising in advising on such investments. This announcement does not constitute a recommendation concerning the IPO. The value of Shares can decrease as well as increase. Potential investors should consult a professional advisor as to the suitability of the IPO for the person concerned. Past performance cannot be relied upon as a guide to future performance.

 

Each of Merrill Lynch International, Goldman Sachs International and Credit Suisse Securities (Europe) Limited, which are authorised by the Prudential Regulation Authority (the "PRA") and regulated by the FCA and the PRA in the United Kingdom, Deutsche Bank AG, London Branch, which is authorised under German Banking Law by BaFin (the Federal Financial Supervisory Authority) and is also authorised by the PRA, but may only be subject to limited regulation by the FCA and by the PRA, and Numis Securities Limited and Jefferies International Limited, which are authorised and regulated by the FCA in the United Kingdom, are acting exclusively for the Company and no-one else in connection with the IPO. They will not regard any other person as their respective clients in relation to the IPO and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, nor for providing advice in relation to the IPO, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

In connection with the IPO, each of the Banks and any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Shares and other securities of the Company or related investments in connection with the IPO or otherwise. Accordingly, references in the Prospectus, once published, to the Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by any of the Banks and any of their respective affiliates acting as investors for their own accounts. In addition, certain of the Banks or their affiliates may enter into financing arrangements and swaps in connection with which they or their affiliates may from time to time acquire, hold or dispose of Shares. None of the Banks nor any of their respective affiliates intend to disclose the extent of any such investments or transactions otherwise than in accordance with any legal or regulatory obligations to do so. 

None of the Banks nor any of their respective subsidiary undertakings, affiliates or any of its or their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from this announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith. Each of the Banks accordingly disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement.

 

In connection with the IPO, the Stabilising Manager, or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Shares or effect other transactions with a view to supporting the market price of the Shares at a higher level than that which might otherwise prevail in the open market. The Stabilising Manager is not required to enter into such transactions and such transactions may be effected on any stock market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings of the Shares on the London Stock Exchange and ending no later than 30 calendar days thereafter. However, there will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilising measures, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Shares above the Offer Price. Save as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the IPO.

 

In connection with the IPO, the Stabilising Manager may, for stabilisation purposes, over-allot Shares up to a maximum of 10 per cent. of the total number of Shares comprised in the IPO. For the purposes of allowing the Stabilising Manager to cover short positions resulting from any such over-allotments and/or from sales of Shares effected by it during the stabilisation period, it is expected that the Over-Allotment Shareholders will grant to the Stabilising Manager, on behalf of the Banks, the Over-Allotment Option pursuant to which the Stabilising Manager may purchase or procure purchasers for the Over-Allotment Shares up to a maximum of 10 per cent. of the total number of Shares comprised in the IPO at the Offer Price. The Over-Allotment Option will be exercisable in whole or in part, upon notice by the Stabilising Manager, at any time for 30 calendar days after the commencement of conditional trading of the Shares on the London Stock Exchange. Any Over-Allotment Shares made available pursuant to the Over-Allotment Option will rank pari passu in all respects with the Shares, including for all dividends and other distributions declared, made or paid on the Shares, will be sold on the same terms and conditions as the Shares being sold or issued in the IPO and will form a single class for all purposes with the other Shares. Save as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the IPO.

 

Certain figures contained in this announcement, including financial information, have been subject to rounding adjustments. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this announcement may not conform exactly with the total figure given.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFLLFZQFXBBL
Date   Source Headline
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement
24th Nov 202310:35 amRNSPDMR Notification
21st Nov 202311:32 amRNSFinal Results of Tender Offer 3.625% Senior Notes
15th Nov 202310:11 amRNSTender Offer Indicative Maximum Acceptance Amount
14th Nov 20235:52 pmRNSPricing of £250 Million Senior Secured Notes
13th Nov 20232:28 pmRNSPre Stabilisation Notice
13th Nov 20239:39 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:30 amRNSTender Offer
13th Nov 20239:27 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:07 amRNS£250 Million Senior Secured Notes Offering
9th Nov 20237:00 amRNSFY24 Interim Results
3rd Oct 20237:25 amRNSTotal Voting Rights
22nd Sep 202311:33 amRNSDirector Appointment and Results of OGM
19th Sep 20238:50 amRNSTiming of announcement of Half Year Results
7th Sep 20232:19 pmRNSNotification of major holdings
7th Sep 20231:31 pmRNSDirector/PDMR Shareholding
5th Sep 20239:48 amRNSAcquisition of Assets from Wilko Ltd (in admin)
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Aug 20239:08 amRNSNotice of Ordinary General Meeting- replace
14th Aug 20237:00 amRNSNotice of Ordinary General Meeting
9th Aug 20234:02 pmRNSGrant of share options to PDMR
2nd Aug 20239:21 amRNSGrant of options to senior managers
2nd Aug 20239:18 amRNSGrant of options to Directors
28th Jul 20237:00 amRNSGroup Trading Director Retention Agreement
27th Jul 20231:42 pmRNSTR-1 Correction Announcement
26th Jul 20234:15 pmRNSTR-1 Notification of major holdings
26th Jul 20233:33 pmRNSBoard change
26th Jul 20238:45 amRNSEGM Voting results announcement
26th Jul 20238:15 amRNSAGM 2023 Voting results announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.